Abstract
Gastritis, esophagitis, and peptic ulcer disease (PUD) present commonly with epigastric pain or dyspepsia. Dyspepsia refers to upper abdominal pain or discomfort and may be associated with fullness, belching, bloating, heartburn, food intolerance, nausea, or vomiting. Dyspepsia is a common problem. Most patients have no organic cause and are defined as having functional dyspepsia.
Similar content being viewed by others
References
Moayyedi PM, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N. ACG and CAG linical guideline: management of dyspepsia. Am J Gastroenterol. 2017;112:988–1013.
Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016 May;150(6):1257–61.
Mounsey A, Barzin A, Rietz A. Functional dyspepsia: evaluation and management. Am Fam Physician. 2020;101(2):84–8.
El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63:871–80.
Sandlers RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122(5):1500–11.
Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308–28.
Gikas A, Triantafillidis JK. The role of primary care physicians in early diagnosis and treatment of chronic gastrointestinal diseases. Int J Gen Med. 2014;7:159–73.
Ling-Zhi Y, Ping Y, Gang-Shi W, et al. Lifestyle intervention for gastroesophageal reflux disease: a national multicenter survey of lifestyle factor effects on gastroesophageal reflux disease in China. Ther Adv Gastroenterol. 2019;12:1–12.
Sigterman KE, van Pinxteren B, Bonis PA, et al. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev. 2013;2013(5):CD002095.
Poly TN, Islam MM, Yang HC, Wu CC, Li YJ. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies. Osteoporos Int. 2019 Jan;30(1):103–14.
Jaynes M, Kumar A. The risks of long term proton pump inhibitors: a critical review. Ther Adv Drug Saf. 2019;10:1–13.
Wileman SM, McCann S, Grant AM, Krukowski ZH, Bruce J. Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev. 2010;(3):CD003243. https://doi.org/10.1002/14651858.CD003243.pub2.
Fashner J, Gitu AC. Diagnosis and treatment of peptic ulcer disease and H. pylori infection. Am Fam Physician. 2015;91:236–42.
Ford AC, Gurusamy KS, Delaney B, Forman D, Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people. Cochrane Database Syst Rev. 2016;2016(4):CD003840.
Heung Up K. Diagnostic and treatment approaches for refractory peptic ulcers. Clin Endosc. 2015;48(4):285–90.
Rantanen T, Udd M, Honkanen T, et al. Effect of omeprazole dose, nonsteroidal anti-inflammatory agents, and smoking on repair mechanisms in acute peptic ulcer bleeding. Dig Dis Sci. 2014;59:2666–74.
Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol. 2012;107:345–60. https://doi.org/10.1038/ajg.2011.480. Published online 7 Feb 2012
Rockey DC, Ahn C, de Melo SW Jr. Randomized pragmatic trial of nasogastric tube placement in patients with upper gastrointestinal tract bleeding. J Investig Med. 2017;65:759.
Stanley AJ, Laine L. Management of acute upper gastrointestinal bleeding. BMJ. 2019;364:l536.
Wilkins T, Wheeler B, Carpenter C. Upper gastrointestinal bleeding in adults: evaluation and management. Am Fam Physician. 2020 Mar 1;101(5):294–300.
Smith A, Baumgartner K, Bositis C. Cirrhosis: diagnosis and management. Am Fam Physician. 2019 Dec 15;100(12):759–70.
Charalampakis N, Economopoulou P, Kotsantis I, et al. Medical management of gastric cancer: a 2017 update. Cancer Med. 2018 Jan;7(1):123–33.
Cats A, Jansen EP, van Grieken NC, et al. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomized phase 3 trial. Lancet Oncol. 2018;19:616–28.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media LLC
About this entry
Cite this entry
Grana, J.L., Heron, C.R., Adelman, A.M. (2020). Gastritis, Esophagitis and Peptic Ulcer Disease. In: Paulman, P., Taylor, R.B., Paulman, A.A., Nasir, L.S. (eds) Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0779-3_94-2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0779-3_94-2
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0779-3
Online ISBN: 978-1-4939-0779-3
eBook Packages: Springer Reference MedicineReference Module Medicine
Publish with us
Chapter history
-
Latest
Gastritis, Esophagitis and Peptic Ulcer Disease- Published:
- 07 October 2020
DOI: https://doi.org/10.1007/978-1-4939-0779-3_94-2
-
Original
Gastritis, Esophagitis, and Peptic Ulcer Disease- Published:
- 24 April 2015
DOI: https://doi.org/10.1007/978-1-4939-0779-3_94-1